PARP inhibitors

Date 11 September 2017
Event ESMO 2017 Congress
Session Update on new therapies for triple negative breast cancer (TNBC) 
Topics Cytotoxic agents
Breast Cancer
Therapy
Biological therapy
Presenter Judy Garber
Authors J. Garber
  • Center For Cancer Genetics And Prevention, Dana-Farber Cancer Institute, 2115 - Boston, MA/US